Unresectable HER2-Negative Breast Carcinoma

specific

A HER2-negative breast adenocarcinoma that is not amenable to surgical resection.

49

Centers

49

Active Trials

Cancer Funding

Top Centers for Unresectable HER2-Negative Breast Carcinoma(49)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
51.0
2
NCI Comprehensive
Active Research Program
51.0
3
NCI Comprehensive
Active Research Program
51.0
4
NCI Comprehensive
Active Research Program
51.0
5
NCI Comprehensive
Active Research Program
51.0
6
NCI Comprehensive
Active Research Program
51.0
7
NCI Comprehensive
Active Research Program
51.0
8
NCI Comprehensive
Active Research Program
51.0
9
NCI Comprehensive
Active Research Program
51.0
10
NCI Comprehensive
Active Research Program
51.0
11
NCI Comprehensive
Active Research Program
51.0
12
NCI Comprehensive
Active Research Program
51.0
13
NCI Comprehensive
Active Research Program
51.0
14
NCI Comprehensive
Active Research Program
51.0
1551.0
16
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
51.0
17
NCI Comprehensive
Active Research Program
51.0
18
NCI Comprehensive
Active Research Program
51.0
19
NCI Comprehensive
Active Research Program
51.0
20
NCI Clinical
Active Research Program
51.0
21
NCI Comprehensive
Active Research Program
51.0
22
NCI Comprehensive
Active Research Program
51.0
23
NCI Comprehensive
Active Research Program
51.0
24
NCI Clinical
Active Research Program
51.0
25
NCI Comprehensive
Active Research Program
51.0
26
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
51.0
27
NCI Comprehensive
Active Research Program
51.0
28
Active Research Program
51.0
29
NCI Comprehensive
Active Research Program
51.0
30
NCI Clinical
Active Research Program
51.0
31
NCI Comprehensive
Active Research Program
51.0
32
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
51.0
33
Active Research Program
51.0
34
NCI Clinical
Active Research Program
51.0
35
NCI Comprehensive
Active Research Program
51.0
36
Active Research Program
51.0
37
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
51.0
38
Active Research Program
51.0
3951.0
40
Active Research Program
51.0
41
Active Research Program
51.0
42
Active Research Program
51.0
43
Active Research Program
51.0
44
Active Research Program
51.0
45
Active Research Program
51.0
4651.0
47
Active Research Program
51.0
48
Active Research Program
51.0
49
Active Research Program
51.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →